India starts manufacturing Oxford’s Coronavirus vaccine

Oxford and AstraZeneca’s vaccine candidate is a frontrunner in the race for the cure of the Coronavirus infection, which has affected more than 15 million people across the globe. The vaccine will be manufactured at the Pune-based Serum Institute of India.

A couple of days back, the promising initial results of the human trials were published by Oxford. The vaccine is now in its third phase of human clinical trials.

Advertisement

Serum Institute of India has already started manufacturing the vaccine for use in India. The Executive Director of Serum Institute of India, Suresh Jadhav said the firm intends on making 2-3 million doses of the vaccine by the end of August, reports The Hindu.

Earlier, the CEO of Serum Institute of India, Adar Poonawalla confirmed that the company would be manufacturing at least a billion doses of vaccines which will cater to other low-income countries as well, along with India.

“Serum Institute of India has entered a manufacturing partnership with AstraZeneca to produce and supply 1 billion doses of the Covid-19 vaccine being developed by Oxford University. These vaccines will be for India and middle and low-income countries across the world (GAVI countries),” Adar Poonawalla told the news agency PTI.